OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Giannis Mountzios: A New ESMO Guide for Thoracic Cancer Care

10 Must-Read Posts In Radiotherapy This Week: July 27- August 2

ctDNA and MRD in NSCLC: Emerging Clinical Applications in the Immunotherapy Era

Pancreatic Cancer FDA Approval Following Landmark Trial Led by Dana-Farber

DART-PHASER: Daily Adaptive Salvage Radiotherapy in Prostate Cancer

Oncology News, Insights, Stories by OncoDaily

Heidi Overton
Career Updates

Donald Trump Nominates Heidi Overton as Next FDA Commissioner

Olympus
Community

From the Marathon 2024 to Olympus 2026: ELPIDA Climbs for Children with Cancer Around the World

ASCO
Breast Oncology

ASCO 2026 Guideline: A Risk-Adapted Framework for Early HR-Positive, HER2-Negative Breast Cancer

Ryan Schoenfeld: Personalized mRNA Vaccines Mark a Turning Point in Cancer Immunotherapy

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Multiple Myeloma in 2026: Comprehensive Clinical Update

Douglas Flora: Making Mental Health Part of Cancer Care

Pavlos Msaouel: New Therapeutic Insights in Renal Medullary Carcinoma

Lacy Hubbard: 5 African Nations Unite With the Elekta Foundation to Eliminate Cervical Cancer

Karen Knudsen’s Exclusive Commentary on the New Moderna Cancer Vaccine

Voices
Neal Shore

Neal Shore: Prostate Cancer Care is Evolving Rapidly and Urologists Are at the Center of It

Shaheenah Dawood: Withdrawl Plans of Lurbinectidine's Indication in 2nd Line Setting of SCLC Patients

University of California San Diego Study Identifies Previously Missed DNA Mutation Pattern in Colorectal Cancer

Julie Fleshman: A New Era of Pancreatic Cancer Treatment

Predictors of Resilience Among Parents of Children With Cancer - CANCaRe Africa

Amal Al Omari and EORTC Advance Understanding of Quality of Life Across Cultures

Nelya Melnitchouk Receives Ukraine’s Prestigious Order of Princess Olga

FDA Approvals
Ziihera

FDA Approves Ziihera With and Without Tislelizumab Plus Chemotherapy for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

Celebrities and Cancer

OncoCalendar

FDA Panel Review of GRAIL’s Galleri Multi-Cancer Early Detection Test

U.S. Food and Drug Administration (FDA)

23 Sep
Multi-Cancer

Practical Approaches to Management of APL in the 21st Century and a Resource-Diverse World - Resonance

Acute Leukemia Research and Care Network (ALRCaN)

28 Aug
Resonance

Clinical Development in LATAM: Brazil Unlocked

24 Sep
Clinical Development in LATAM

The ELPIDA Foundation for Children with Cancer and Leukemia

ELPIDA Foundation for Children with Cancer and Leukemia

02 Sep
ELPIDA Foundation

The Global Health Catalyst Summit 2026

Global Health Catalyst

18 Sep
Global Health Catalyst Summit

Immune-oncology
ctDNA and MRD in NSCLC: Emerging Clinical Applications in the Immunotherapy Era

ctDNA and MRD in NSCLC: Emerging Clinical Applications in the Immunotherapy Era

CAR T-Cell Therapy Death Rate: Treatment-Related Mortality, Causes of Death, and Risk Factors

CD20 × CD3 Bispecific Antibodies in B-Cell Lymphoma: Real-World Safety, Efficacy, and Healthcare Use in Spain

5 Must-Read Posts About CAR-T This Week

Lung Cancer Immunotherapy: Real-World Survival and Costs in France

INTerpath-001 Trial: Personalized mRNA Cancer Vaccine for Melanoma

Tumor Mutational Burden in Immunotherapy: Why TMB Is More Than a Number

Gastrointestinal-Oncology
FDA Daraxonrasib

FDA Approves Daraxonrasib: First-in-Class RAS Inhibitor for Metastatic Pancreatic Cancer

SKYSCRAPER-07: Atezolizumab ± Tiragolumab After dCRT in Unresectable ESCC

TALENTOP: Liver Resection After Atezolizumab and Bevacizumab in Locally Advanced HCC

10 Must-Read Posts In GI Oncology This Week

ctDNA Identifies High Recurrence Risk After Resection of Stage I–III Biliary Tract Cancer

Comprehensive Genomic Profiling in GI Oncology: Real-World Impact and Challenges

ESMO Clinical Practice Guideline Express Update: Daraxonrasib for Metastatic Pancreatic Cancer

Breast-Oncology
ASCO

ASCO 2026 Guideline: A Risk-Adapted Framework for Early HR-Positive, HER2-Negative Breast Cancer

Artificial Intelligence Brings TILs Into the Digital Era

Oncotype DX-Guided Chemotherapy Associated With Improved Survival in HR+/HER2− Breast Cancer

Insights From I-SPY2 Trial: Dual Immune Checkpoint Blockade Shows Promise in High-Risk ERBB2-Negative Early Breast Cancer

TQB2102 and the Evolution of HER2 Antibody-Drug Conjugates: Exploring the Role of Payload Optimisation in Breast Cancer

HER2DX Predicts Pathologic Complete Response in HER2-Positive Breast Cancer After Neoadjuvant THP

Neo-CheckRay: iSBRT and Durvalumab in High-Risk ER+/HER2− Breast Cancer

Lung-Oncology
Thymic

Are We Irradiating the Immune System? Thymic Dose Emerges as a Potential Risk Factor in NSCLC

Ivonescimab Plus Chemotherapy Shows Powerful Benefit After EGFR-TKI Resistance in Advanced Lung Cancer

Dato-DXd in Lung Cancer: International Experts Define New Strategies to Manage ADC Toxicities

Lung Cancer Screening in Women: 5 Breakthrough Insights Highlight New Risk Groups

MET Exon 14 Skipping NSCLC: DECIDE-MET Trial Addresses a Critical Question in First-Line Treatment Selection

KEYNOTE-671: Five-Year Data Confirm Durable Benefit of Perioperative Pembrolizumab in Early-Stage NSCLC

RAS-Mediated Resistance Emerges Across Oncogene-Driven NSCLC

Genitourinary-Oncology
DART-PHASER

DART-PHASER: Daily Adaptive Salvage Radiotherapy in Prostate Cancer

Personalizing Treatment Intensity in Prostate Cancer: Less Is More… Until It Isn’t?

10 Must-Read Posts In GU Oncology This Week

Ahmed Mohsen Elalfy: Lessons From Practicing Oncology Across Egypt, Saudi Arabia, and Canada

Local Renal Cell Carcinoma Recurrence: Salvage Treatment Outcomes

AVENANCE: Real-World Avelumab Maintenance in Advanced Urothelial Carcinoma

ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC

OncoDaily-AI
Claude

Claude Is Now Available at No Cost to Start for 10,000 Qualified Scientists

Ron DiGiaimo: Very Interesting Presentations at ABS Regarding AI Use

Samer Al Hadidi: The Hidden Risks of AI-Assisted Medical Knowledge Dissemination

Maria García Requesens: The Growing Role of AI in Oncology Drug Development

Jorge Reis-Filho: AI’s Next Breakthrough Could Be Biomedical Discovery

Anthropic's AI Protein Design Run: 354 Binders, 15 Targets

Anirudh Joshi: A New AI Biomarker to Predict Aggressiveness of MIBC

Oncology Tech
CAR-T

CAR-T Has Conquered Blood Cancer. Can Biotech Make It Work Against Solid Tumors?

Revolution Medicines Has Its First Approved Drug. Now Comes the Harder Part.

Moderna Stock Surge Explained: How INTerpath-001 Added $45 Billion in a Day and What Oncologists Should Actually Watch

Anthropic's AI Protein Design Run: 354 Binders, 15 Targets

Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma

AstraZeneca-Bristol Myers Merger Denied: What It Exposed

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

Hematology
CANOVA Trial t(11;14) R/R Multiple Myeloma

CANOVA Trial: Higher Responses but No Significant PFS Benefit With Venetoclax in t(11;14) R/R Multiple Myeloma

Inflammation and JAK2 Burden in Polycythemia Vera: Interferon, Ruxolitinib, and Clonal Control 

Multiple Myeloma in 2026: Comprehensive Clinical Update

Central Nervous System (CNS) Lymphoma: Reaching the Tumor Across CNS Barriers

VEXAS Syndrome: Is It More a Matter of Inflammation or Hematopoietic Clonality?

Venetoclax + HMA in Newly Diagnosed AML: What Do Real-World Data Show?

BeOne, BeOne Care Foundation and The Max Foundation Renew BRUKINSA Access Partnership for CLL in LMICs

Radiotherapy
radiotherapy

10 Must-Read Posts In Radiotherapy This Week: August 17 -23

EANO Consensus Statement Guides Diagnosis and Management of Radiation Necrosis

Neoadjuvant SBRT and Immunotherapy Show Potential in High-Risk ER+/HER2− Breast Cancer

Call for Papers: “Radiation Oncology in 2026” Special Series

10 Must-Read Posts In Radiotherapy This Week: August 10-16

Mayo Clinic Reports First Clinical Series of Minibeam Radiation Therapy for Superficial Malignancies

TREASURE Trial Raises Safety Concerns Over Thoracic Radiotherapy in ES-SCLC

OncoDaily TV
WHO

Mission is possible: WHO said 2030 – Rwanda said 2027: Dr. Sabin Nsanzimana

Current Landscape

The Current Landscape & Future of CAR-T in Aggressive B-Cell Lymphoma

Experts by Experience

Experts by Experience with Carmen Monge

Fighting Cervical Cancer

From Engineering to Fighting Cervical Cancer

Dr. Beatrice Addai Wiafe

Fighting Cancer With Peace And Love: Dr. Beatrice Addai Wiafe

Maggie Smith breast cancer

Dame Maggie Smith and Courageus Breast Cancer Journey: Filming Harry Potter During Chemotherapy

Petra Jankowska

Leading with Humanity in Modern Oncology: Dr. Petra Jankowska

Princess Dina

Episode 18: Global Health Dialogues with Princess Dina and Dr Urvi Shah

Empowering Oncologist

Empowering Oncologists: How to Fight Burnout? Dr. Mimi Knoll

Dr. C.S. Pramesh

The Power of Collaboration in Fighting Cancer: Dr. C.S. Pramesh

Tommy Bramley

Making Innovative Oncology Therapies Accessible for All Patients: Tommy Bramley

Rolando Camacho

Beyond the Policy Paper: Turning Cancer Plans into Real Impact: Dr. Rolando Camacho

Not To Miss
Rasonque

FDA Approves Rasonque (Daraxonrasib), First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer

Agenus Reports No Recurrences and Deep Pathologic Responses With Neoadjuvant BOT+BAL in Resectable Colon Cancer

Dolly Parton Dies at 80 After Brief Battle With Cancer

Top 10 Cancer Research Grants Open to Researchers Worldwide

Astellas Doses First Patient in Phase 3 ASP2138 Trial for CLDN18.2-Positive Gastric and GEJ Cancer

AAADV Leaders on the Shifting Landscape of Global Cancer Drug Development

FDA Grants Priority Review to GSK’s Jemperli for dMMR/MSI-H Locally Advanced Rectal Cancer

OncoGrants
Prevention and Population Programme

Cancer Research UK Prevention and Population Programme Award 2026

Cancer Research UK

Cancer Research UK Early Detection and Diagnosis Programme Award 2026

Hold’em for Life Cancer Fellowships

Hold’em for Life Cancer Fellowships 2026 at the University of Toronto

Cancer Research Alliance

Pershing Square Sohn Cancer Research Alliance Cancer Prize 2027

Prostate Cancer UK Internship Programme

Windsor Fellowship–Prostate Cancer UK Internship Programme 2026/27

Bio-Resource Coordinating Hub

CIHR Team Grant for National Cancer Data and Bio-Resource Coordinating Hub 2026–2027

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Robert E. Reiter

Robert E. Reiter

Oncologists Location Los Angeles, USA
Stephen Nimer

Stephen Nimer

Oncologists Location Miami, USA
Christine Parseghian

Christine Parseghian

Oncologists Location Houston, USA
Alexandra Müller

Alexandra Müller

Oncologists Location Freiburg, Germany
Zainab Shinkafi-Bagudu

Zainab Shinkafi-Bagudu

Oncologists Location Abuja, Nigeria
Jay M. Lee

Jay M. Lee

Oncologists Location Los Angeles, USA
Jyoti Malhotra

Jyoti Malhotra

Oncologists Location Duarte, USA
Sarah Muma

Sarah Muma

Oncologists Location Kijabe, Kenya

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Jacob Scott

Jacob Scott: Bringing Rectal Cancer Radiotherapy Into the Genomic Era

Valsamo Anagnostou

Valsamo Anagnostou: New Molecular Response Marker Could Transform Immunotherapy Monitoring

Pashtoon Kasi

Pashtoon Kasi: NEST Trial Reports 100% Disease-Free Survival to Date in Localized Colon Cancer

Walid Kamoun

Walid Kamoun: The Next Challenge for RAS Inhibitors - Acquired Resistance

Felipe Couñago

Felipe Couñago: Whole-Pelvis Radiotherapy Shows No Overall Survival Benefit

Al-Ola Abdallah

Al-Ola A Abdallah: What Did We Learn From the CANOVA Phase III Trial?

OncoDaily Medical Journal

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts

Radiation Oncology

10.69690/ODMJ-018-0826-7920

Short-Course Palliative Radiotherapy for Tumour-Related Bleeding in End-of-Life Care: A Focused Literature Review
Abstracts

Pediatric Oncology

10.69690/ODMJ-018-0826-7952

FLASH radiotherapy: A Potential Way to Protect the Developing Brain in Pediatric Oncology
Abstracts

GI Oncology

10.69690/ODMJ-018-0826-7947

Real World Clinical Insights in Combination of Trifluridine-Tipiracil with Bevacizumab for Metastatic Colorectal Cancer
Abstracts

Hematology

10.69690/ODMJ-018-0826-7945

Plasma cell survival: The impact of extracellular ATP
Abstracts

Breast Cancer

10.69690/ODMJ-018-0826-7965

A Systematic Comparison of ICG Fluorescence vs Dual-Tracer Sentinel Lymph Node Biopsy in Breast Cancer Staging
Abstracts

Immunotherapy

10.69690/ODMJ-018-0826-7715

Promoter DNA methylation regulates MHC class II transcription in human ovarian cancer
Abstracts